Shaily Engineering Plastics Limited — PPTs, 08-08-2026: Investor Presentation

Shaily Engineering Plastics reported solid Q1 FY27 results! 💪 Revenue grew 14% YoY to 280.7 Cr. Healthcare was the star, soaring 85% to 142.4 Cr and driving overall growth, while Industrial also rose 25%. Consumer segment declined 24% due to weak demand in Europe/USA home furnishings.

This growth is fueled by Healthcare's global focus, pushing exports to 58.1% of revenue, plus better machine utilization (+150 bps). Recent wins include new projects across FMCG, LED lights, Appliances, Auto, and crucial approvals for Semaglutide pens in Canada/Brazil, alongside two new IP-led healthcare platforms.

PAT jumped 17% YoY to 48.0 Cr. EBITDA increased 18% to 83.3 Cr (margins at 29.7%), and Gross Profit Margin expanded to 56.6%. The company maintains strong capital efficiency with RoCE at 39.0% and Debt/Equity at a healthy 0.2. Management emphasizes healthcare's strong traction and global pharma supplies as key for future growth.